{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:43:15Z","timestamp":1761237795946},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,3,24]],"date-time":"2011-03-24T00:00:00Z","timestamp":1300924800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1743-422x-8-137","type":"journal-article","created":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T16:28:48Z","timestamp":1301675328000},"source":"Crossref","is-referenced-by-count":12,"title":["Antiviral propierties of 5,5'-dithiobis-2-nitrobenzoic acid and bacitracin against T-tropic human immunodeficiency virus type 1"],"prefix":"10.1186","volume":"8","author":[{"given":"Humberto H","family":"Lara","sequence":"first","affiliation":[]},{"given":"Liliana","family":"Ixtepan-Turrent","sequence":"additional","affiliation":[]},{"given":"Elsa N","family":"Garza-Trevi\u00f1o","sequence":"additional","affiliation":[]},{"given":"Samantha M","family":"Flores-Tevi\u00f1o","sequence":"additional","affiliation":[]},{"given":"Gadi","family":"Borkow","sequence":"additional","affiliation":[]},{"given":"Cristina","family":"Rodriguez-Padilla","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,3,24]]},"reference":[{"issue":"14","key":"1249_CR1","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1056\/NEJM199909303411406","volume":"341","author":"AS Fauci","year":"1999","unstructured":"Fauci AS: The AIDS epidemic--considerations for the 21st century. N Engl J Med 1999,341(14):1046-1050. 10.1056\/NEJM199909303411406","journal-title":"N Engl J Med"},{"issue":"13","key":"1249_CR2","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1056\/NEJM199803263381301","volume":"338","author":"FJ Palella Jr","year":"1998","unstructured":"Palella FJ Jr, Delaney KM, Moorman AC, et al.: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998,338(13):853-860. 10.1056\/NEJM199803263381301","journal-title":"N Engl J Med"},{"issue":"3","key":"1249_CR3","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1086\/314623","volume":"179","author":"E Vittinghoff","year":"1999","unstructured":"Vittinghoff E, Scheer S, O'Malley P, Colfax G, Holmberg SD, Buchbinder SP: Combination antiretroviral therapy and recent declines in AIDS incidence and mortality. J Infect Dis 1999,179(3):717-720. 10.1086\/314623","journal-title":"J Infect Dis"},{"issue":"10","key":"1249_CR4","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1097\/00002030-199810000-00004","volume":"12","author":"J Balzarini","year":"1998","unstructured":"Balzarini J, Naesens L, Verbeken E, et al.: Preclinical studies on thiocarboxanilide UC-781 as a virucidal agent. AIDS 1998,12(10):1129-1138. 10.1097\/00002030-199810000-00004","journal-title":"AIDS"},{"issue":"5136","key":"1249_CR5","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1126\/science.8235617","volume":"262","author":"AS Fauci","year":"1993","unstructured":"Fauci AS: Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 1993,262(5136):1011-1018. 10.1126\/science.8235617","journal-title":"Science"},{"issue":"3","key":"1249_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1006\/smim.1993.1019","volume":"5","author":"G Pantaleo","year":"1993","unstructured":"Pantaleo G, Graziosi C, Fauci AS: The role of lymphoid organs in the pathogenesis of HIV infection. Semin Immunol 1993,5(3):157-163. 10.1006\/smim.1993.1019","journal-title":"Semin Immunol"},{"issue":"Suppl A","key":"1249_CR7","first-page":"S85","volume":"13","author":"DL Van","year":"1999","unstructured":"Van DL, Rosenberg ZF: Microbicides and barrier methods in HIV prevention. AIDS 1999,13(Suppl A):S85-S92.","journal-title":"AIDS"},{"issue":"10","key":"1249_CR8","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.1073\/pnas.91.10.4559","volume":"91","author":"HJ Ryser","year":"1994","unstructured":"Ryser HJ, Levy EM, Mandel R, DiSciullo GJ: Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction. Proc Natl Acad Sci USA 1994,91(10):4559-4563. 10.1073\/pnas.91.10.4559","journal-title":"Proc Natl Acad Sci USA"},{"issue":"52","key":"1249_CR9","doi-asserted-by":"publisher","first-page":"50579","DOI":"10.1074\/jbc.M204547200","volume":"277","author":"A Gallina","year":"2002","unstructured":"Gallina A, Hanley TM, Mandel R, et al.: Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry. J Biol Chem 2002,277(52):50579-50588. 10.1074\/jbc.M204547200","journal-title":"J Biol Chem"},{"issue":"4","key":"1249_CR10","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1189\/jlb.0608354","volume":"86","author":"CX Santos","year":"2009","unstructured":"Santos CX, Stolf BS, Takemoto PV, et al.: Protein disulfide isomerase (PDI) associates with NADPH oxidase and is required for phagocytosis of Leishmania chagasi promastigotes by macrophages. J Leukoc Biol 2009,86(4):989-998. 10.1189\/jlb.0608354","journal-title":"J Leukoc Biol"},{"issue":"6034","key":"1249_CR11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/317267a0","volume":"317","author":"JC Edman","year":"1985","unstructured":"Edman JC, Ellis L, Blacher RW, Roth RA, Rutter WJ: Sequence of protein disulphide isomerase and implications of its relationship to thioredoxin. Nature 1985,317(6034):267-270. 10.1038\/317267a0","journal-title":"Nature"},{"issue":"47","key":"1249_CR12","doi-asserted-by":"publisher","first-page":"29399","DOI":"10.1074\/jbc.272.47.29399","volume":"272","author":"HF Gilbert","year":"1997","unstructured":"Gilbert HF: Protein disulfide isomerase and assisted protein folding. J Biol Chem 1997,272(47):29399-29402. 10.1074\/jbc.272.47.29399","journal-title":"J Biol Chem"},{"issue":"5","key":"1249_CR13","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0092-8674(00)81430-0","volume":"93","author":"DC Chan","year":"1998","unstructured":"Chan DC, Kim PS: HIV entry and its inhibition. Cell 1998,93(5):681-684. 10.1016\/S0092-8674(00)81430-0","journal-title":"Cell"},{"issue":"5","key":"1249_CR14","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1086\/318823","volume":"183","author":"E Fenouillet","year":"2001","unstructured":"Fenouillet E, Barbouche R, Courageot J, Miquelis R: The catalytic activity of protein disulfide isomerase is involved in human immunodeficiency virus envelope-mediated membrane fusion after CD4 cell binding. J Infect Dis 2001,183(5):744-752. 10.1086\/318823","journal-title":"J Infect Dis"},{"issue":"4","key":"1249_CR15","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1124\/mol.104.008276","volume":"67","author":"R Barbouche","year":"2005","unstructured":"Barbouche R, Lortat-Jacob H, Jones IM, Fenouillet E: Glycosaminoglycans and protein disulfide isomerase-mediated reduction of HIV Env. Mol Pharmacol 2005,67(4):1111-1118. 10.1124\/mol.104.008276","journal-title":"Mol Pharmacol"},{"issue":"5","key":"1249_CR16","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1074\/jbc.M205467200","volume":"278","author":"R Barbouche","year":"2003","unstructured":"Barbouche R, Miquelis R, Jones IM, Fenouillet E: Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion. J Biol Chem 2003,278(5):3131-3136. 10.1074\/jbc.M205467200","journal-title":"J Biol Chem"},{"issue":"5","key":"1249_CR17","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1182\/blood-2003-05-1390","volume":"103","author":"I Markovic","year":"2004","unstructured":"Markovic I, Stantchev TS, Fields KH, et al.: Thiol\/disulfide exchange is a prerequisite for CXCR4-tropic HIV-1 envelope-mediated T-cell fusion during viral entry. Blood 2004,103(5):1586-1594. 10.1182\/blood-2003-05-1390","journal-title":"Blood"},{"issue":"16","key":"1249_CR18","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S1359-6446(05)03550-6","volume":"10","author":"HJ Ryser","year":"2005","unstructured":"Ryser HJ, Fluckiger R: Progress in targeting HIV-1 entry. Drug Discov Today 2005,10(16):1085-1094. 10.1016\/S1359-6446(05)03550-6","journal-title":"Drug Discov Today"},{"issue":"Suppl 12","key":"1249_CR19","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1186\/1471-2105-9-S12-S14","volume":"9","author":"U Gowthaman","year":"2008","unstructured":"Gowthaman U, Jayakanthan M, Sundar D: Molecular docking studies of dithionitrobenzoic acid and its related compounds to protein disulfide isomerase: computational screening of inhibitors to HIV-1 entry. BMC Bioinformatics 2008,9(Suppl 12):S14. 10.1186\/1471-2105-9-S12-S14","journal-title":"BMC Bioinformatics"},{"issue":"21","key":"1249_CR20","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.2174\/138161209788682343","volume":"15","author":"F Hatahet","year":"2009","unstructured":"Hatahet F, Ruddock LW: Modulating proteostasis: peptidomimetic inhibitors and activators of protein folding. Curr Pharm Des 2009,15(21):2488-2507. 10.2174\/138161209788682343","journal-title":"Curr Pharm Des"},{"issue":"11","key":"1249_CR21","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1089\/aid.1990.6.1281","volume":"6","author":"V Ciminale","year":"1990","unstructured":"Ciminale V, Felber BK, Campbell M, Pavlakis GN: A bioassay for HIV-1 based on Env-CD4 interaction. AIDS Res Hum Retroviruses 1990,6(11):1281-1287.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"4","key":"1249_CR22","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2174\/0929867003375146","volume":"7","author":"F Lebon","year":"2000","unstructured":"Lebon F, Ledecq M: Approaches to the design of effective HIV-1 protease inhibitors. Curr Med Chem 2000,7(4):455-477.","journal-title":"Curr Med Chem"},{"issue":"5","key":"1249_CR23","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1074\/jbc.M205467200","volume":"278","author":"R Barbouche","year":"2003","unstructured":"Barbouche R, Miquelis R, Jones IM, Fenouillet E: Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion. J Biol Chem 2003,278(5):3131-3136. 10.1074\/jbc.M205467200","journal-title":"J Biol Chem"},{"issue":"9","key":"1249_CR24","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.1073\/pnas.90.9.4112","volume":"90","author":"R Mandel","year":"1993","unstructured":"Mandel R, Ryser HJ, Ghani F, Wu M, Peak D: Inhibition of a reductive function of the plasma membrane by bacitracin and antibodies against protein disulfide-isomerase. Proc Natl Acad Sci USA 1993,90(9):4112-4116. 10.1073\/pnas.90.9.4112","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"1249_CR25","doi-asserted-by":"publisher","first-page":"e3206","DOI":"10.1371\/journal.pone.0003206","volume":"3","author":"S Naganawa","year":"2008","unstructured":"Naganawa S, Yokoyama M, Shiino T, et al.: Net positive charge of HIV-1 CRF01_AE V3 sequence regulates viral sensitivity to humoral immunity. PLoS One 2008,3(9):e3206. 10.1371\/journal.pone.0003206","journal-title":"PLoS One"},{"issue":"1","key":"1249_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00126334-200009010-00001","volume":"25","author":"JR Trujillo","year":"2000","unstructured":"Trujillo JR, Goletiani NV, Bosch I, et al.: T-tropic sequence of the V3 loop is critical for HIV-1 infection of CXCR4-positive colonic HT-29 epithelial cells. J Acquir Immune Defic Syndr 2000,25(1):1-10. 10.1097\/00042560-200009010-00001","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"1249_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1006\/viro.1998.9185","volume":"246","author":"JR Trujillo","year":"1998","unstructured":"Trujillo JR, Rogers RA, Brain JD: Shared antigenic epitopes on the V3 loop of HIV-1 gp120 and proteins on activated human T cells. Virology 1998,246(1):53-62. 10.1006\/viro.1998.9185","journal-title":"Virology"},{"issue":"10","key":"1249_CR28","doi-asserted-by":"publisher","first-page":"6122","DOI":"10.1128\/JVI.79.10.6122-6133.2005","volume":"79","author":"QE Yang","year":"2005","unstructured":"Yang QE, Stephen AG, Adelsberger JW, et al.: Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4. J Virol 2005,79(10):6122-6133. 10.1128\/JVI.79.10.6122-6133.2005","journal-title":"J Virol"},{"issue":"4","key":"1249_CR29","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1128\/JVI.66.4.2232-2239.1992","volume":"66","author":"J Kimpton","year":"1992","unstructured":"Kimpton J, Emerman M: Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J Virol 1992,66(4):2232-2239.","journal-title":"J Virol"},{"issue":"1","key":"1249_CR30","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1074\/jbc.273.1.404","volume":"273","author":"PL Jones","year":"1998","unstructured":"Jones PL, Korte T, Blumenthal R: Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors. J Biol Chem 1998,273(1):404-409. 10.1074\/jbc.273.1.404","journal-title":"J Biol Chem"},{"issue":"8","key":"1249_CR31","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1128\/AAC.00210-08","volume":"52","author":"A Hombrouck","year":"2008","unstructured":"Hombrouck A, Van RB, Michiels M, et al.: Preclinical evaluation of 1H-benzylindole derivatives as novel human immunodeficiency virus integrase strand transfer inhibitors. Antimicrob Agents Chemother 2008,52(8):2861-2869. 10.1128\/AAC.00210-08","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"1249_CR32","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1124\/mol.58.5.1100","volume":"58","author":"M Witvrouw","year":"2000","unstructured":"Witvrouw M, Fikkert V, Pluymers W, et al.: Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase\/integrase) in the virus replicative cycle. Mol Pharmacol 2000,58(5):1100-1108.","journal-title":"Mol Pharmacol"},{"issue":"14","key":"1249_CR33","doi-asserted-by":"publisher","first-page":"7427","DOI":"10.1128\/JVI.78.14.7427-7437.2004","volume":"78","author":"J Auwerx","year":"2004","unstructured":"Auwerx J, Stevens M, Van Rompay AR, et al.: The phenylmethylthiazolylthiourea nonnucleoside reverse transcriptase (RT) inhibitor MSK-076 selects for a resistance mutation in the active site of human immunodeficiency virus type 2 RT. J Virol 2004,78(14):7427-7437. 10.1128\/JVI.78.14.7427-7437.2004","journal-title":"J Virol"},{"issue":"10","key":"1249_CR34","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1128\/AAC.47.10.3109-3116.2003","volume":"47","author":"M Stevens","year":"2003","unstructured":"Stevens M, Pannecouque C, De CE, Balzarini J: Novel human immunodeficiency virus (HIV) inhibitors that have a dual mode of anti-HIV action. Antimicrob Agents Chemother 2003,47(10):3109-3116. 10.1128\/AAC.47.10.3109-3116.2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"1249_CR35","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1128\/JVI.78.7.3210-3222.2004","volume":"78","author":"ES Svarovskaia","year":"2004","unstructured":"Svarovskaia ES, Barr R, Zhang X, et al.: Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long-terminal-repeat-circle junctions. J Virol 2004,78(7):3210-3222. 10.1128\/JVI.78.7.3210-3222.2004","journal-title":"J Virol"},{"issue":"6","key":"1249_CR36","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/S0960-894X(03)00059-3","volume":"13","author":"X Zhang","year":"2003","unstructured":"Zhang X, Pais GC, Svarovskaia ES, et al.: Azido-containing aryl beta-diketo acid HIV-1 integrase inhibitors. Bioorg Med Chem Lett 2003,13(6):1215-1219. 10.1016\/S0960-894X(03)00059-3","journal-title":"Bioorg Med Chem Lett"},{"key":"1249_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1477-3155-8-15","volume":"8","author":"HH Lara","year":"2010","unstructured":"Lara HH, Ixtepan-Turrent L, Garza-Trevino EN, Rodriguez-Padilla C: PVP-coated silver nanoparticles block the transmission of cell-free and cell-associated HIV-1 in human cervical culture. J Nanobiotechnology 2010, 8: 15. 10.1186\/1477-3155-8-15","journal-title":"J Nanobiotechnology"},{"issue":"5","key":"1249_CR38","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/00002030-200303280-00002","volume":"17","author":"A Zussman","year":"2003","unstructured":"Zussman A, Lara L, Lara HH, Bentwich Z, Borkow G: Blocking of cell-free and cell-associated HIV-1 transmission through human cervix organ culture with UC781. AIDS 2003,17(5):653-661. 10.1097\/00002030-200303280-00002","journal-title":"AIDS"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-8-137.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1743-422X-8-137\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-8-137.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T20:25:22Z","timestamp":1592425522000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-8-137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,24]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1249"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-8-137","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,24]]},"article-number":"137"}}